Home » Topics » Regulatory » Patents

Patents
RSS

University of Pittsburg presents new radioprotectants

Sep. 17, 2012

Vertex Pharmaceuticals patents Na(V) channel inhibitors

Sep. 17, 2012

Research at Actelion yields new P2X7 receptor antagonists

Sep. 17, 2012

Actelion designs novel orexin receptor antagonists

Sep. 17, 2012

Cancer Therapeutics CRC synthesizes novel agents for cancer

Sep. 14, 2012

New antiviral agents patented by German researchers

Sep. 14, 2012

Concert Pharmaceuticals discloses novel deuterated hydroxybutyrate analogues

Sep. 14, 2012

New agents for parasitic infections patented by U.S. team

Sep. 14, 2012

Indian researchers disclose novel agents for cancer

Sep. 14, 2012

Boehringer Ingelheim presents new PDE9A inhibitors

Sep. 14, 2012

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...